RxDoctor Payments DataLook up a doctor →

William Flores

Physician Assistant · Beverly Hills, CANPI 1942530571

Payments from drug & device makers

$103,159in general payments, 2019–2025

Across 1,315 payments — averaging $78.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Gilead$61K
  • Viiv Healthcare Company$18K
  • Napo Pharmaceuticals Inc$7K
  • Merck$4K
  • EMD Serono, Inc.$2K
  • Amgen$1K
  • plus $11K from 54 others

What the payments were for

  • Speaking & faculty fees$48,07551%
  • Travel & lodging$16,20717%
  • Food & beverage$29,18731%
  • Education$1910%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Gilead305$60,543
Viiv Healthcare Company300$18,450
Napo Pharmaceuticals Inc51$6,540
Merck55$3,863
EMD Serono, Inc.74$1,648
Amgen(2 entities)55$1,350
AbbVie46$1,057
Johnson & Johnson(2 entities)42$936
Novo Nordisk60$933
Theratechnologies Inc.23$749
Lilly USA, LLC26$564
Axsome Therapeutics, Inc.21$430
Jazz Pharmaceuticals Inc.16$429
Idorsia Pharmaceuticals US Inc20$387
Takeda Pharmaceuticals U.S.A., Inc.21$380
Pfizer17$376
Regeneron Healthcare Solutions, Inc.5$338
Antares Pharma, Inc.15$336
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC15$330
Bausch Health US, LLC15$313
Nestle Healthcare Nutrition Inc.15$300
AstraZeneca(2 entities)12$239
Aimmune Therapeutics, Inc.8$201
Angiodynamics, Inc.1$197
Janssen Products, LP2$149
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)5$136
GSK6$133
Dynavax Technologies Corporation6$132
Corium, LLC4$121
Argenx US, Inc.4$115
Halozyme Inc5$114
Exact Sciences6$111
Biohaven Pharmaceuticals, Inc.5$110
Eisai Inc.6$100
Currax Pharmaceuticals LLC5$91
Biohaven Pharmaceutical Holding Company Ltd.4$88
Phathom Pharmaceuticals, Inc.3$74
Alk-abello, Inc2$50
Hologic Sales And Service, LLC2$49
Amarin Pharma, Inc.2$48
Biogen2$42
Harmony Biosciences LLC1$41
Shield Therapeutics Inc2$37
Tolmar, Inc.2$37
ARS Pharmaceuticals Operations, Inc.2$35
Clarus Therapeutics Inc.2$35
GRT US Holding, Inc.1$34
Vanda Pharmaceuticals Inc.1$32
Genentech USA, Inc.1$32
Endo Pharmaceuticals Inc.2$31
Boston Scientific1$29
Lundbeck LLC1$29
Alkermes, Inc.1$26
Irhythm Technologies, Inc.1$26
Redhill Biopharma Inc.1$25
GE HealthCare1$24
Optos, Inc.1$20
Seqirus USA Inc1$19
Virtus Pharmaceuticals LLC1$18
Azurity Pharmaceuticals, Inc.1$16

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$103,159 in reported general payments places this provider in the 95th percentile of 10,423 physician assistant providers in California.

See all physician assistant providers in California

Most prescribed under Part D

DrugClaimsCost to plans & patients
SerostimSomatropin104$2,092,956
BiktarvyBictegrav/Emtricit/Tenofov Ala128$534,672
CabenuvaCabotegravir/Rilpivirine45$309,672
RukobiaFostemsavir Tromethamine28$259,460
JulucaDolutegravir/Rilpivirine54$187,945
TriumeqAbacavir/Dolutegravir/Lamivudi47$173,803
DovatoDolutegravir Sodium/Lamivudine47$137,273
MytesiCrofelemer33$120,809
TivicayDolutegravir Sodium32$91,188
OtezlaApremilast15$76,725
PercocetOxycodone Hcl/Acetaminophen13$75,043
PrezcobixDarunavir/Cobicistat25$66,864
DescovyEmtricitabine/Tenofov Alafenam28$62,104
PifeltroDoravirine26$45,786
Dupixent PenDupilumab11$40,564

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
EMD Serono, Inc.Serostim$1,648$2,092,956104 claims
Viiv Healthcare CompanyCabenuva, Rukobia, Juluca, Triumeq, Dovato$18,450$1,159,340253 claims
GileadBiktarvy, Descovy, Vemlidy$60,543$612,359167 claims
Napo Pharmaceuticals IncMytesi$6,540$120,80933 claims
AmgenOtezla$1,350$76,72515 claims
MerckPifeltro, Isentress, Dulera$3,863$75,05450 claims
Endo Pharmaceuticals Inc.Percocet$31$75,04313 claims
Johnson & JohnsonPrezcobix$936$66,86425 claims
Aimmune Therapeutics, Inc.Zenpep$201$39,80527 claims
Antares Pharma, Inc.Xyosted$336$24,18934 claims
Novo NordiskOzempic$933$20,30719 claims
AstraZenecaFarxiga$239$19,13317 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 10,423 physician assistant providers in California.

Other physician assistant in Beverly Hills

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →